FI925501L - Imidazolfoereningar, deras framstaellning och anvaendning - Google Patents

Imidazolfoereningar, deras framstaellning och anvaendning Download PDF

Info

Publication number: FI925501L
Authority: FI; Finland
Prior art keywords: imidazolfoereningar; deras framstaellning; framstaellning och; och anvaendning; anvaendning
Prior art date: 1991-12-03

Application number

FI925501A

Other languages

English (en)

Finnish (fi)

Other versions

FI925501A7 (fi

FI925501A0 (fi

Inventor

Oskar Axelsson

Mikkel Thaning

Peter Moldt

Original Assignee

Neurosearch As

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1991-12-03

Filing date

1992-12-03

Publication date

1993-06-04

1992-12-03 Application filed by Neurosearch As filed Critical Neurosearch As

1992-12-03 Publication of FI925501A0 publication Critical patent/FI925501A0/fi

1993-06-04 Publication of FI925501A7 publication Critical patent/FI925501A7/fi

1993-06-04 Publication of FI925501L publication Critical patent/FI925501L/fi

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D235/30—Nitrogen atoms not forming part of a nitro radical
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Pain & Pain Management (AREA)
Obesity (AREA)
Hematology (AREA)
Diabetes (AREA)
Heart & Thoracic Surgery (AREA)
Urology & Nephrology (AREA)
Cardiology (AREA)
Vascular Medicine (AREA)
Hospice & Palliative Care (AREA)
Psychiatry (AREA)
Endocrinology (AREA)
Rheumatology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Epoxy Resins (AREA)
Developing Agents For Electrophotography (AREA)
Dental Preparations (AREA)
Optical Fibers, Optical Fiber Cores, And Optical Fiber Bundles (AREA)

FI925501A 1991-12-03 1992-12-03 Imidazolfoereningar, deras framstaellning och anvaendning FI925501L (fi)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US80175491A	1991-12-03	1991-12-03

Publications (3)

Publication Number	Publication Date
FI925501A0 FI925501A0 (fi)	1992-12-03
FI925501A7 FI925501A7 (fi)	1993-06-04
FI925501L true FI925501L (fi)	1993-06-04

Family

ID=25181970

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
FI925501A FI925501L (fi)	1991-12-03	1992-12-03	Imidazolfoereningar, deras framstaellning och anvaendning

Country Status (15)

Country	Link
US (1)	US5314903A (de)
EP (1)	EP0545845B1 (de)
JP (1)	JPH072796A (de)
KR (1)	KR100220303B1 (de)
AT (1)	ATE134622T1 (de)
AU (1)	AU649899B2 (de)
CA (1)	CA2084233A1 (de)
DE (1)	DE69208604T2 (de)
DK (1)	DK0545845T3 (de)
ES (1)	ES2084972T3 (de)
FI (1)	FI925501L (de)
GR (1)	GR3019439T3 (de)
NO (1)	NO300832B1 (de)
NZ (1)	NZ245287A (de)
ZA (1)	ZA929268B (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DK154092D0 (da) *	1992-12-23	1992-12-23	Neurosearch As	Imidazolforbindelser, deres fremstilling og anvendelse
GB9413724D0 (en) *	1994-07-07	1994-08-24	Wellcome Found	Therapeutic nucleosides
DE69924493T2 (de) *	1998-07-02	2005-09-15	Neurosearch A/S	Kaliumkanal-blockierende mittel
US6194447B1 (en)	1998-07-02	2001-02-27	Neurosearch A/S	Bis (benzimidazole) derivatives serving as potassium blocking agents
AU760250B2 (en)	1998-12-04	2003-05-08	Neurosearch A/S	New benzimidazolone-, benzoxazolone-, or benzothiazolone derivatives as ion channel modulating agents
WO2004064835A1 (en) *	2003-01-17	2004-08-05	Neurosearch A/S	Use of ion channel modulating agents for treating pain
US20060135506A1 (en) *	2003-04-22	2006-06-22	Pharmacia Corporation	Compositions of a cyclooxygenase-2 selective inhibitor and a calcium modulating agent for the treatment of pain, inflammation or inflammation mediated disorders
US20050159403A1 (en) *	2003-04-22	2005-07-21	Pharmacia Corporation	Compositions of a cyclooxygenase-2 selective inhibitor and a calcium modulating agent for the treatment of central nervous system damage
US7166603B2 (en)	2003-07-23	2007-01-23	Bristol-Myers Squibb Co.	Dihydropyrimidone inhibitors of calcium channel function
WO2005007124A2 (en)	2003-07-23	2005-01-27	Bristol-Myers Squibb Company	Substituted dihydropyrimidine inhibitors of calcium channel function
DE10342503A1 (de) *	2003-09-12	2005-04-14	Merck Patent Gmbh	Benzyl-Benzimidazolylderivate
US7504431B2 (en)	2004-04-16	2009-03-17	Bristol-Myers Squibb Company	Sulfonyl amide inhibitors of calcium channel function
US8921406B2 (en)	2005-08-21	2014-12-30	AbbVie Deutschland GmbH & Co. KG	5-ring heteroaromatic compounds and their use as binding partners for 5-HT5 receptors
GB0715103D0 (en) *	2007-08-03	2007-09-12	Lectus Therapeutics Ltd	Calcium ion channel modulators and uses thereof
US10501421B1 (en) *	2017-01-27	2019-12-10	Vanderbilt University	Substituted benzimidazoles as modulators of Ras signaling
MX2023001758A (es) *	2020-08-11	2023-04-11	Univ Michigan State	Potenciadores de proteasoma y usos de los mismos.

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4004016A (en) *	1975-08-11	1977-01-18	E. R. Squibb & Sons, Inc.	Amino-benzimidazole derivatives
CA2009542C (en) *	1989-02-10	2000-03-14	Albert A. Carr	Cyclic guanidines as calcium antagonists
DE3928177A1 (de) *	1989-04-08	1991-02-28	Thomae Gmbh Dr K	Benzimidazole, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
US5210091A (en) *	1991-06-24	1993-05-11	Neurosearch A/S	Imidazole compounds and their use

1992
- 1992-11-18 US US07/978,131 patent/US5314903A/en not_active Expired - Lifetime
- 1992-11-20 DE DE69208604T patent/DE69208604T2/de not_active Expired - Lifetime
- 1992-11-20 ES ES92610081T patent/ES2084972T3/es not_active Expired - Lifetime
- 1992-11-20 AT AT92610081T patent/ATE134622T1/de not_active IP Right Cessation
- 1992-11-20 DK DK92610081.9T patent/DK0545845T3/da active
- 1992-11-20 EP EP92610081A patent/EP0545845B1/de not_active Expired - Lifetime
- 1992-11-26 NZ NZ245287A patent/NZ245287A/en not_active IP Right Cessation
- 1992-11-26 AU AU29651/92A patent/AU649899B2/en not_active Ceased
- 1992-11-30 ZA ZA929268A patent/ZA929268B/xx unknown
- 1992-12-01 KR KR1019920022960A patent/KR100220303B1/ko not_active Expired - Fee Related
- 1992-12-01 CA CA002084233A patent/CA2084233A1/en not_active Abandoned
- 1992-12-02 JP JP4323417A patent/JPH072796A/ja not_active Withdrawn
- 1992-12-02 NO NO924646A patent/NO300832B1/no unknown
- 1992-12-03 FI FI925501A patent/FI925501L/fi unknown
1996
- 1996-03-27 GR GR960400825T patent/GR3019439T3/el unknown

Also Published As

Publication number	Publication date
NO924646D0 (no)	1992-12-02
NZ245287A (en)	1995-04-27
AU649899B2 (en)	1994-06-02
NO924646L (no)	1993-06-04
ZA929268B (en)	1993-06-29
FI925501A7 (fi)	1993-06-04
KR100220303B1 (ko)	1999-09-15
AU2965192A (en)	1993-06-10
DK0545845T3 (da)	1996-08-05
NO300832B1 (no)	1997-08-04
JPH072796A (ja)	1995-01-06
US5314903A (en)	1994-05-24
GR3019439T3 (en)	1996-06-30
FI925501A0 (fi)	1992-12-03
ATE134622T1 (de)	1996-03-15
DE69208604T2 (de)	1996-09-05
EP0545845A1 (de)	1993-06-09
ES2084972T3 (es)	1996-05-16
CA2084233A1 (en)	1993-06-04
EP0545845B1 (de)	1996-02-28
DE69208604D1 (de)	1996-04-04

Similar Documents

Publication	Publication Date	Title
FI935795L (fi)	1993-12-22	Ctl4a-receptor, fusionsproteiner innehaollande denna och anvaendningar daerav
FI923337L (fi)	1993-01-24	Organiska fluorenylmetallfoereningar, framstaellning och anvaendning daerav
FI922977L (fi)	1992-12-28	Heterocykliska foereningar, deras framstaellning och anvaendning
FI923366L (fi)	1993-01-28	5-lediga heterocykler, foerfarande foer deras framstaellning och dessa foereningar innehaollande laekemedel
FI923960L (fi)	1993-03-07	5-ledad heterocykler, foerfarande foer deras framstaellning och dessa foereningar innehaollande laekemedel
FI921030L (fi)	1992-09-13	Cykliska ureaderivat, dessa foereningar innehaollande laekemedel och foerfarande foer deras framstaellning
FI923691L (fi)	1993-02-20	Cykliska iminoderivat, dessa foereningar innehaollande farmaceutiska blandningar och foerfarande foer deras framstaellning
FI924687L (fi)	1993-04-19	Heterobiarylderivat, dessa foereningar innehaollande laekemedel och foerfarande foer deras framstaellning
FI923223A7 (fi)	1993-01-16	Alkenylgrupper omfattande siloxankopolymerer, deras framstaellning och anvaendning
FI923775L (fi)	1993-02-24	2-piperazinonfoereningar, deras framstaellning och anvaendning
FI934426L (fi)	1993-10-08	Tiazolidindionderivat, framstaellning och anvaendning daerav
FI924084L (fi)	1993-03-14	Tramadol-n-oxidmaterial, enantiomerer och kompositioner daerav och deras anvaendning
FI923947A7 (fi)	1993-03-07	Foerfarande foer pulsbreddsmodulation foer oekad linearitet, minskad kommutationsfoerlust och oekad utspaenning i en vaexelriktare/omriktare
FI912760A0 (fi)	1991-06-07	Skivfilter och filterelement foer skivfilter.
FI921049L (fi)	1992-09-16	Hydrazonderivat, deras framstaellning och anvaendning
FI922390L (fi)	1992-12-01	Initiatorsuspensioner, deras framstaellning och anvaendning
FI912138A7 (fi)	1992-08-14	Luftvaexlingssystem foer andningsskydd och andningsskydd.
FI934680L (fi)	1993-10-22	Arylmorfolin, framstaellning och anvaending
FI923168L (fi)	1993-01-11	Sammansaettning haerstammande fraon baernstensglykan, framstaellningsfoerfarande och tillaempningar
FI912567A0 (fi)	1991-05-28	Ytbelaeggningskomposition och foerfarande.
FI922377L (fi)	1992-11-26	Glasblandning, daerav framstaellda glasfibrer och deras framstaellningsfoerfarande
FI923266A7 (fi)	1993-01-17	Faestprofil foer ramar foer vaeggelement, doerrar och foenster
FI924053L (fi)	1993-03-15	Substituerade aminopropaner, foerfarande foer deras framstaellning och deras anvaendning
FI921553L (fi)	1992-10-16	Bitumenfri blandning, byggnadsmaterialblandning och vattenemulsion
FI925639A0 (fi)	1992-12-11	Isoxazolylimidazolderivat, foerfarande foer deras framstaellning och deras anvaendning i laekemedel